Back to PCVX
Janus Henderson Group Ltd. → PCVX
Janus Henderson Group Ltd. PCVX Position History
Vaxcyte, Inc. • Healthcare
Quarters held
23
Latest value
$244K
Q3 2026
Peak value
$995M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $7.2M |
| Q4 2025 | $601M |
| Q4 2025 | $485K |
| Q4 2025 | $247K |
| Q4 2025 | $8.9M |
| Q1 2026 | $9.9M |
| Q1 2026 | $276K |
| Q1 2026 | $599K |
| Q1 2026 | $10.3M |
| Q1 2026 | $2.8M |
| Q1 2026 | $936.4M |
| Q1 2026 | $276K |
| Q1 2026 | $9.9M |
| Q1 2026 | $599K |
| Q1 2026 | $2.8M |
| Q1 2026 | $10.3M |
| Q1 2026 | $936.4M |
| Q3 2026 | $995M |
| Q3 2026 | $10.1M |
| Q3 2026 | $10.3M |
| Q3 2026 | $3.4M |
| Q3 2026 | $573K |
| Q3 2026 | $244K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $244K | 4.3K | — | — |
| Q3 2026 | $573K | 10.1K | — | — |
| Q3 2026 | $3.4M | 59.0K | — | — |
| Q3 2026 | $10.3M | 181.8K | — | — |
| Q3 2026 | $10.1M | 177.6K | — | — |
| Q3 2026 | $995M | 17.49M | — | — |
| Q1 2026 | $936.4M | 16.17M | — | — |
| Q1 2026 | $10.3M | 176.8K | — | — |
| Q1 2026 | $2.8M | 47.4K | — | — |
| Q1 2026 | $599K | 10.3K | — | — |
| Q1 2026 | $9.9M | 170.1K | — | — |
| Q1 2026 | $276K | 4.8K | — | — |
| Q1 2026 | $936.4M | 16.17M | — | — |
| Q1 2026 | $2.8M | 47.4K | — | — |
| Q1 2026 | $10.3M | 176.8K | — | — |
| Q1 2026 | $599K | 10.3K | — | — |
| Q1 2026 | $276K | 4.8K | — | — |
| Q1 2026 | $9.9M | 170.1K | — | — |
| Q4 2025 | $8.9M | 192.2K | — | — |
| Q4 2025 | $247K | 5.3K | — | — |
| Q4 2025 | $485K | 10.5K | — | — |
| Q4 2025 | $601M | 13.02M | — | — |
| Q4 2025 | $7.2M | 155.5K | — | — |